Lumibird

Lumibird: FINANCIAL COMMUNICATIONS AGENDA

20 12 2021 11:45:00 提供 Nasdaq GlobeNewswire

Lumibird Maintains Double-Digit Pro Forma Growth in the Third Quarter

25 10 2021 11:45:00 提供 Nasdaq GlobeNewswire

LUMIBIRD: 2021 HALF-YEAR EARNINGS: LUMIBIRD CAPITALIZES ON THE RECOVERY, TRIPLING ITS CURRENT OPERATING INCOME

21 9 2021 11:45:00 提供 Nasdaq GlobeNewswire

Lumibird: 2021 First-Half Revenues: €75.5m, +13% Pro Forma

26 7 2021 11:45:00 提供 Nasdaq GlobeNewswire

Lumibird Completes Purchase of Areva's 37% Stake in Cilas

26 7 2021 01:30:00 提供 Nasdaq GlobeNewswire

LUMIBIRD IN EXCLUSIVE BID TO BUY AREVA'S STAKE IN CILAS

19 7 2021 11:45:00 提供 Nasdaq GlobeNewswire

Lumibird Appoints Its Csr Officer

28 6 2021 01:30:00 提供 Nasdaq GlobeNewswire

Lumibird: GENERAL MEETING STREAMED LIVE ON MAY 4, 2021

28 4 2021 06:11:01 提供 Nasdaq GlobeNewswire

ERRATUM - LUMIBIRD: 2021 FIRST-QUARTER REVENUES

26 4 2021 12:54:40 提供 Nasdaq GlobeNewswire

LUMIBIRD: 2021 FIRST-QUARTER REVENUES

26 4 2021 11:45:00 提供 Nasdaq GlobeNewswire

Lumibird Medical’s Glaucoma Treatment Potential Further Strengthened by the Latest Egs Recommendations

13 4 2021 11:45:00 提供 Nasdaq GlobeNewswire

Lumibird: Access to Preparatory Documents for the Combined General Meeting on May 4, 2021

29 3 2021 11:45:00 提供 Nasdaq GlobeNewswire

Lumibird / 2020 Earnings: Current Operating Margin of Over 11% in a Health Crisis Context

16 3 2021 12:45:00 提供 Nasdaq GlobeNewswire

Lumibird: Agreement Signed to Acquire the Saab Group’s Defense Laser Rangefinder Business

03 3 2021 01:30:00 提供 Nasdaq GlobeNewswire

Lumibird: 2020 Full-Year Revenues in Line With Expectations at €126.7m

25 1 2021 11:45:00 提供 Nasdaq GlobeNewswire

LUMIBIRD CONFIRMS ITS INTEREST IN CILAS

21 1 2021 01:30:00 提供 Nasdaq GlobeNewswire

LUmibird: FINANCIAL COMMUNICATIONS AGENDA

05 1 2021 11:45:00 提供 Nasdaq GlobeNewswire